Home » 2016 » April (Page 2)

Shire jumps as Vyvanse drug helps it to beat earnings forecast

LONDON Strong demand for Shire’s (SHP.L) top-selling Vyvanse drug helped to lift first-quarter earnings by a better than expected 12 percent, boosting the London-listed group’s shares ahead of its $32…

Black raspberry improves cardiovascular risk in metabolic syndrome

Contact our news editors For any corrections of factual information, or to contact our editorial team, please see our contact page. Please note: Any medical information published on this website…

Scandal-hit trust patients ‘at risk’

Scandal-hit trust patients ‘at risk’

Image copyright JusticeforLB Image caption Connor Sparrowhawk, 18, who died at Slade House, had epilepsy and experienced seizures The NHS mental health trust which ran a care unit where a…

In China’s tougher drug market, minnows open back door for ‘Big Pharma’

SHANGHAI Armed with Beijing funds and friends in the right places, Chinese drug minnows are thriving, luring money from ‘Big Pharma’ majors struggling to restore the strong growth they once…

‘Secret of youth’ in ginger gene

‘Secret of youth’ in ginger gene

Image copyright Thinkstock Scientists say they have made a leap in knowing why some people retain their youthful looks while others age badly. They found the first part of human…

Quest Diagnostics says its Zika virus test gets U.S. approval

Quest Diagnostics Inc said it has received emergency authorization from the U.S. Food and Drug Administration to sell the first commercially developed diagnostic test for Zika in the United States,…

U.S. teen births hit historic low with plunge in minority rate

The birth rate among teenagers in the United States has fallen to a historic low, with births by black and Hispanic teens down by nearly half over the past decade,…

Gene therapy reverses sight loss

Gene therapy reverses sight loss

Image copyright BBC News Image caption A life transformed: Joe Pepper was slowly going blind until a gene therapy reversed his sight loss. A genetic therapy has improved the vision…

AbbVie forges deeper into cancer, as clock ticks for Humira

AbbVie Inc placed another big bet on new cancer drugs on Thursday with a $5.8 billion acquisition that could lessen its dependence on arthritis treatment Humira, the world’s top selling…

Sanofi launches $9.3 blillion fight for U.S. cancer firm Medivation

LONDON/PARIS French drugmaker Sanofi went public with a $9.3 billion offer to buy Medivation on Thursday, setting up what could be a lengthy takeover battle after the U.S. cancer firm…